<DOC>
	<DOCNO>NCT00519883</DOCNO>
	<brief_summary>This randomize , phase III trial 12 week exercise program , follow 36 week voluntary , self-directed exercise program ( total 48 week ) compare standard supportive care . The purpose trial determine whether exercise program well standard supportive care decrease muscle joint ache ( musculoskeletal symptom ) result aromatase inhibitor . Hypothesis An exercise program include stretch , strengthen aerobic component may improve physical quality life among woman musculoskeletal symptom take aromatase inhibitor .</brief_summary>
	<brief_title>Randomized Anastrozole Exercise Trial</brief_title>
	<detailed_description />
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Women adjuvant AI least 6 week . The presence musculoskeletal symptom . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 ER PgR positive early breast cancer , stag I , II III Completion adjuvant chemotherapy ( give ) primary breast cancer surgery . Be willing switch Anastrozole another AI Signed write informed consent Metastatic disease ( image lab require absence clinical suspicion metastasis ) Evidence history inflammatory arthropathy ( example , rheumatoid arthritis ) Any medical condition ( example , significant heart disease ) would prevent subject complete exercise program . Unable take Aromatase Inhibitor ( AI ) Planned secondary reconstruction procedure 48 week study period Any medical , physical , geographic , emotional , economic condition judgement clinician/study doctor , would make individual unable unlikely able exercise three time week 12 week . Unable complete study log book questionnaire ( unable read write English one home adequately ) . The use exogeneous estrogen and/or progesterone except Estring natural plant estrogen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Anastrozole</keyword>
	<keyword>Exercise</keyword>
</DOC>